117 related articles for article (PubMed ID: 28970003)
1. Identification of underlying and transfusion-related platelet qualitative alterations in the hemato-oncologic patient.
Vicente-Ayuso C; Papadopoulos P; Villa-Fajardo M; Prieto B; Álvarez-Carmona AM; Mateo-Morales M; Pérez-López C; Peña-Cortijo A; Polo-Zarzuela M; Sáez I; Martín MP; Benavente-Cuesta C; González-Fernández A; Martínez-Martínez R; Zwaginga JJ; Seghatchian J; Gutiérrez L
Transfus Apher Sci; 2017 Oct; 56(5):756-768. PubMed ID: 28970003
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
3. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
Kander T; Tanaka KA; Norström E; Persson J; Schött U
Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
[TBL] [Abstract][Full Text] [Related]
4. Plasma thrombopoietin concentrations in response to platelet transfusion therapy.
Möller P; Andersson PO; Andersson AC; Wadenvik H
Acta Haematol; 2000; 102(3):131-4. PubMed ID: 10692675
[TBL] [Abstract][Full Text] [Related]
5. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
6. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
7. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
[TBL] [Abstract][Full Text] [Related]
9. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin following transfusion of platelets in preterm neonates.
Kline A; Mackley A; Taylor SM; McKenzie SE; Paul DA
Platelets; 2008 Sep; 19(6):428-31. PubMed ID: 18925510
[TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions in haematology patients: are we using them appropriately?
Estcourt LJ; Birchall J; Lowe D; Grant-Casey J; Rowley M; Murphy MF
Vox Sang; 2012 Nov; 103(4):284-93. PubMed ID: 22775395
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.
Weisdorf DJ; DeFor T; Nichol J; Panoskaltsis-Mortari A; Blazar BR
Bone Marrow Transplant; 2000 Apr; 25(7):711-5. PubMed ID: 10745255
[TBL] [Abstract][Full Text] [Related]
13. Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients: A prospective observational study.
Benediktsson S; Lazarevic V; Nilsson L; Kjeldsen-Kragh J; Schött U; Kander T
Eur J Haematol; 2017 Dec; 99(6):559-568. PubMed ID: 28952164
[TBL] [Abstract][Full Text] [Related]
14. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
Slichter SJ
Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
[TBL] [Abstract][Full Text] [Related]
15. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
[TBL] [Abstract][Full Text] [Related]
18. Consensus and controversies in platelet transfusion.
Marwaha N; Sharma RR
Transfus Apher Sci; 2009 Oct; 41(2):127-33. PubMed ID: 19717344
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
20. A flow cytometric technique using thiazole orange to detect platelet engraftment following pediatric stem-cell transplants.
Figuerres E; Olszewski M; Kletzel M
Cytotherapy; 2001; 3(4):277-83. PubMed ID: 12171716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
